Article: CUBICIN Approved for S. aureus Bloodstream Infections in South Korea and Taiwan.

Article: IV Antibiotic CUBICIN Approved for Marketing in Canada.
Business Wire;  September 25, 2007 ;     700+ words ... ... Oryx distribution system. CUBICIN, originally introduced in ... international markets where CUBICIN has received regulatory approval ... EU, Switzerland, Taiwan, South Korea, and Israel. Cubist markets CUBICIN in the U.S. through its ...

Article: Cubicin granted marketing approval in Europe; ...
M2 Presswire;  January 24, 2006 ;     700+ words ... ... 24 January 2006-Chiron Corporation: Cubicin granted marketing approval in Europe ... Commission has granted marketing approval for CUBICIN(R) (daptomycin), a first-in ... Liechtenstein and Norway. Under the approval, CUBICIN is indicated for the treatment of complicated ...

Article: Cubicin(R) Granted Marketing Approval in Europe; ...
Business Wire;  January 23, 2006 ;     700+ words ... ... Commission has granted marketing approval for CUBICIN(R) (daptomycin), a first-in ... Liechtenstein and Norway. Under the approval, CUBICIN is indicated for the treatment of complicated ... caused by Gram-positive bacteria. CUBICIN is expected to become available in the ...

Article: FDA Approves Cubicin, Previously Cidecin, an Antibiotic ...
Business Wire;  September 12, 2003 ;     700+ words ... ... Drug Administration (FDA) has approved Cubicin(TM) (daptomycin for injection; previously ... by early November. "The approval of CUBICIN is particularly important as we face the ... become less effective. The approval of CUBICIN gives physicians a new weapon against ...

Article: FDA Accepts CUBICIN(R) sNDA and Grants Priority Review.
Business Wire;  November 21, 2005 ;     700+ words ... ... Application (sNDA) for Cubist's antibiotic CUBICIN(R) (daptomycin for injection) has ... By granting priority review status to CUBICIN, the FDA has established a target date ... March 24, 2006. Cubist submitted the CUBICIN sNDA on September 26, 2005, requesting ...

Article: Cubist Pharmaceuticals' CUBICIN Approved for Additional ...
Business Wire;  September 6, 2007 ;     700+ words ... ... CBST) said today that its IV antibiotic CUBICIN[R](daptomycin for injection) is ... other parts of the world for marketing CUBICIN, is based on data from Cubist's landmark ... and soft-tissue infections (cSSTI). CUBICIN was originally approved by the European ...

Article: $40-50 MILLION IN CUBICIN SALES PROJECTED FOR 2004.(Cubist ...
Biotech Financial Reports;  May 1, 2004 ;     700+ words ... ... information on the launch of its flagship product, Cubicin (daptomycin for injection). CUBICIN was launched in November 2003 in the U.S ... comfortable providing an expected range for CUBICIN sales this year. Based on our confidence in ...